Tissue Diagnostics Market Size, Leading Players, Segments Analysis and Forecast Report 2024

A recent trend observed in the tissue diagnostics industry is increasing usage of immunohistochemistry products as companion diagnostics devices. Increasing prevalence of cancer has fuelled the demand of better diagnostic techniques, which could detect cancer in the earliest stage. According to the WHO, in 2012, there were 14 million new cancer cases and 8.2 million cancer related deaths worldwide.

The global tissue diagnostics market is categorized on the basis of product type, technology, application, and end-user. Based on product type, the tissue diagnostics market can be categorized as instruments and consumables. On the basis of technology, the tissue diagnostics market is categorized as digital pathology and workflow management, in situ hybridization, immunohistochemistry, and special staining. The immunohistochemistry segment leads the global tissue diagnostics market in terms of market size.

To Learn More About this report at: http://bit.ly/2Q76du2

Geographically, North America will be leading the global tissue diagnostics market in the coming years due to high prevalence of cancer cases, high healthcare expenditure, and presence of a large number of hospitals and pharmaceutical companies. Additionally, the legislative reform of Affordable Care Act in the U.S. is also expected to drive the North American market in the coming years.

Asia-Pacific is the fastest growing region in the global tissue diagnostics market. The major reasons for the fastest growth in the region are aging population, increasing disposable income, and improving healthcare infrastructure. Moreover, the tissue diagnostics marketis growing due to large unexplored tissue diagnostics market and large population base suffering with cancer in the emerging economies, such as India and China, of Asia-Pacific region.

Some of the major players operating in the global tissue diagnostics market are F. Hoffmann-La Roche AG., Sigma Aldrich Corporation, Abbott, Biogenex Laboratories, BioSB, Cell Signalling Technology Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, GE Healthcare, and Siemens Healthcare.

Read More

Weight Management Market Size, Share, Segment Analysis and Forecast Report 2024

The global weight management market size is growing significantly due to escalating technological advancement, increasing innovation in weight management ingredients, and increasing prevalence of obesity. According to National Health and Nutrition Examination Survey (NHANES) in 2009-10, more than 78 million U.S. adults were obese. Similarly, as per World Health Organization (WHO), approximately 2.8 million people die each year due to obesity.

The weight management market is categorized on the basis of diet and equipment. On the basis of diet, the market can be categorized as meals, supplements, and beverages. Diet leads the market due to increasing prevalence of obese cases, technological advancement and increasing health consciousness of people. The meals can be further segmented as meal replacement, organic food and others; whereas, supplements can be segmented as protein, fiber and others.

To Learn More About this report at: http://bit.ly/38Z2l7h

On the basis of equipment, the market can be categorized as fitness equipment, and surgical equipment. The fitness equipment includes cardiovascular training equipment and strength training equipment. The cardiovascular training equipment leads the market under fitness equipment category. The surgical equipment further includes minimally invasive surgical equipment and non-invasive surgical equipment. Minimally invasive surgical equipment includes gastric bypass surgery, laparoscopic adjustable gastric banding system, laparoscopic sleeve gastrectomy, and others. Non-invasive surgical equipment includes intragastric balloon systems, endoscopic stapling, endobarrier and others.

Asia-Pacific is the fastest growing region in the global weight management market. The major reasons for the fastest growth of weight management market in the region are increasing medical tourism, large pool of patients, and increasing healthcare expenditure. Moreover, the weight management market is growing due to increasing awareness of weight management, and refining healthcare infrastructure in the emerging countries, such as India and China, of Asia-Pacific region.

Global Weight Management Market Key Players:

• Amer Sports
• Technogym SPA
• Weight Watchers International Inc.
• Ediets.Com Inc.
• Jenny Craig Inc.
• Medtronic Inc.
• Kellogg Company
• Brunswick Corporation
• Jenny Craig Inc.
• Atkins Nutritionals Inc.
• Herbalife Ltd.
• Apollo Endosurgery Inc.
• Nutrisystem Inc.
• Cyber International, Inc.
• Johnson & Johnson.

Read More

Next-Generation Sequencing Market Size Will Make a Huge Impact in Near Future

The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years.

The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market.

The global next-generation sequencing market is categorized as technology type, sequencing workflow, applications, and end-users. Based on technology type, the next-generation sequencing market is categorized as pyrosequencing, ion-semiconductor sequencing, sequencing by synthesis, single molecule realtime sequencing, and sequencing by ligation. The sequencing by synthesis segment leads the global next-generation sequencing market. Based on sequencing workflow, the next-generation sequencing market is categorized as next-generation pre-sequencing, next-generation sequencing platforms, and next-generation sequencing services.

Inquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=next-generation-sequencing-market

Based on applications, the next-generation sequencing market can be categorized as diagnostics, drug discovery, animal and agriculture research, personalized medicine, and others. End-users of next-generation sequencing include academic and research institutes, biopharmaceutical and biotechnology companies, hospitals, and others. Academic and research institutes lead the global next-generation sequencing market.

Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.

Read More

Latin America Wound Dressing Market Size, Regional Analysis, Key Players and Future Scope

A recent P&S Intelligence study has estimated the 2024 value of the Latin America wound dressing market to be $400.9 million. The key drivers of the domain’s growth are rising prevalence of diabetes, growing geriatric population and number of patients with chronic wounds, and high brain injury rate.

When segmented by type, the domain can be categorized into traditional dressings and advanced dressings. In 2018, the advanced dressings category is estimated to account for more than 60.0% share in the LATAM wound dressing market due to the rising utilization of such products in complex application areas as well as the growing number of people with chronic diseases. Advanced dressings further consist of the hydrocolloids, foams, alginates, films, collagen, hydrogels, wound contact layers, superabsorbent, hydrofiber, and others subcategories. Among all these, foam dressings are the most preferred type of advanced dressing in the Latin American region.

Both, acute and chronic wounds, can be managed with wound dressing. Now, chronic wounds consume more dressing material compared to the acute type due to their more severe nature. It is being estimated that the wound dressing demand for chronic wounds will contribute a $200 million revenue to the Latin America (LATAM) wound dressing market in 2018. Coming to the acute wounds category, it is further subdivided into burns, and surgical and traumatic wounds. Of these, the surgical and traumatic wounds subdivision is expected to generate the larger revenue in 2018 (91.0% share).

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=latam-wound-dressing-market

The domain is expected to grow the most in Brazil during the forecast period, primarily due to government research and development programs and increasing chronic injury incidents in the country. For instance, Brazilian Synchrotron Light Laboratory carried out a research, according to which nitric oxide (NO) may prove effective as a dressing material ingredient for chronic wounds. The research seeks to develop a product based on the use of supramolecular poly (acrylic acid) hydrogel, which contains an NO donor in the form of S-nitrosoglutathione along with the nanometric micelles of another polymer.

LATAM wound dressing market players, such as DeRoyal Industries Inc., Hollister Incorporated, Smith & Nephew plc, Johnson & Johnson, 3M Company, Mölnlycke Health Care AB, BSN Medical GmbH, Acelity L.P. Inc., Coloplast A/S., B. Braun Melsungen AG, and HARTMANN GROUP., are benefiting from product approvals in the region.

Read More

DNA Sequencing Market Trends, Business Strategies and Opportunities with Key Players Analysis 2024

The global DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2023). This is attributed to the extensive use of consumables for sample preparation, cluster generation, and other processes during the course of experiments.

The key trends observed in the DNA sequencing industry are surge in clinical assessment through personalized genomics, increase in oncological research, demand for easy and fast clinical diagnosis, and adoption of high throughput technology.

Various factors leading to the growth of the DNA sequencing industry include the rise in technological advancements, increase in collaborations & partnerships of key players, and global increase in genome mapping programs. Additionally, rise in R&D investment also enhances the growth of the market and provides lucrative opportunities to the key players. Some of the challenges hindering the growth of the market are concerns related to the accuracy & standardization, along with the ethical & legal limitations posed with DNA sequencing.

Download report sample at: https://www.psmarketresearch.com/market-analysis/dna-sequencing-market/report-sample

The DNA sequencing industry provides immense opportunities for the new players to grow, due to the eminence of latest innovative technology in the market. Subsequently, the key players are also exploring opportunities by leveraging their precedence in technological advancement. The advent of next generation DNA sequencing (NGS) also provides opportunities for the market players to grow in the future.

Some of the key players in the global market include Illumina, Inc, Pacific Biosciences of California, Inc., Siemens AG, ZS Genetics, Inc, Abbott Laboratories, Li-Cor, Inc., F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, and Agilent Technologies, Inc.

Read More

How is Unhealthy Lifestyle of People Driving Complementary and Alternative Medicines Market?

Due to globalization and urbanization, the lifestyle of people across the world has changed drastically. At the present time, a large number of people are suffering from medical conditions such as stress, obesity, hypertension, and insomnia. For instance, as per the Our World in Data, in 2017, 3.4% and 3.8% people across the globe were suffering from anxiety and depression, respectively. Apart from this, the prevalence of chronic diseases is on the rise as well; for example, the number of people suffering from diabetes grew from 108 million in 1980 to 422 million in 2014, according to the World Health Organization (WHO). The symptoms of these medical conditions can be managed by alternative therapies and medicines, including meditation, yoga, and tai chi, which is why the demand for complementary and alternative medicines (CAM) is rising.

The remedies or treatments that are used in place of conventional medical treatments, such as chemotherapy, surgery, allopathic medicines, and radiation therapy, are called CAM. Some examples of CAM are chiropractic, acupuncture, traditional medicine (herbal and ayurvedic), yoga, reiki, and homeopathy.

To Learn More About this Report at: http://bit.ly/35RBbg4

As per a research conducted by P&S Intelligence, in 2018, the global complementary and alternative medicines market reached a value of $192.0 billion and is predicted to register a 6.0% CAGR in the near future. The various types of CAM are mind-body intervention-based, nature-based, energy-based, and manipulative body-based. Among all these, the largest demand was created for nature-based CAM during 2014–2018. This was attributed to the increased requirement for organic and natural medications, which have less side-effects as compared to allopathic drugs. Ayurveda, mud therapy, and homeopathy are primary types of nature-based CAM.

One of the key reasons for the growing demand for CAM is the side-effects associated with allopathic medications. Several incidents of side-effects, such as diarrhea, vomiting, internal bleeding, dizziness, seizure, and insomnia, have been reported by patients taking allopathic medicines. For instance, aspirin, one of the most common drugs, is believed to cause side-effects including vomiting, heartburn, and seizures. These side-effects can happen because of various reasons, such as drug-food interaction and drug-drug interaction. Attributed to these factors, the consumers have started adopting alternative therapies and medicines, as they help in the management of several diseases without any major side-effects.

Read More